A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Ellison, Gillian ^a   Donald, Emma ^a   McWalter, Gael ^a   Knight, Lucy ^a,b   Fletcher, Lynn ^a   Sherwood, James ^a   Cantarini, Mireille ^a   Orr, Maria ^a   Speake, Georgina ^a  

^a ASTRAZENECA   (United Kingdom)

^b IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR; DNA;

AMPLIFICATION REFRACTORY MUTATION SYSTEM; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DNA SEQUENCE; EMBEDDING; EXON; GENE MUTATION; GENETIC PROCEDURES; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MELANOMA; MUTATIONAL ANALYSIS; ONCOGENE RAS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; COMPARATIVE STUDY; GENETICS; LUNG TUMOR; METHODOLOGY; NEOPLASM; NUCLEOTIDE SEQUENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; SKIN TUMOR;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; LUNG NEOPLASMS; MELANOMA; NEOPLASMS; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 77957316871     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-132     Document Type: Article

References (22)

1. Personalized medicine in oncology: the future is now. RL Schilsky, Nat Rev Drug Discov 2010 9 363 366 10.1038/nrd3181 20431568
2. Pathogenesis of lung cancer signalling pathways: roadmap for therapies. E Brambilla A Gazdar, Eur Respir J 2009 33 1485 1497 10.1183/09031936.00014009 19483050
3. The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. M Koshiba K Ogawa S Hamazaki T Sugiyama O Ogawa T Kitajima, Pathol Res Pract 1993 189 66 72 8390645
4. Patterns of somatic mutation in human cancer genomes. C Greenman P Stephens R Smith GL Dalgliesh C Hunter G Bignell H Davies J Teague A Butler C Stevens,, et al. Nature 2007 446 153 158 10.1038/nature05610 17344846
5. The consensus coding sequences of human breast and colorectal cancers. T Sjoblom S Jones LD Wood DW Parsons J Lin TD Barber D Mandelker RJ Leary J Ptak N Silliman,, et al. Science 2006 314 268 274 10.1126/science.1133427 16959974
6. Is the DNA sequence the gold standard in genetic testing? Quality of molecular genetic tests assessed. E Bakker, Clin Chem 2006 52 557 558 10.1373/clinchem.2005.066068 16595822
7. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. S Ogino T Kawasaki M Brahmandam L Yan M Cantor C Namgyal M Mino-Kenudson GY Lauwers M Loda CS Fuchs, J Mol Diagn 2005 7 413 421 16049314
8. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. J Li L Wang H Mamon MH Kulke R Berbeco GM Makrigiorgos, Nat Med 2008 14 579 584 10.1038/nm1708 18408729
9. The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. JC Fox J England P White G Ellison K Callaghan NR Charlesworth J Hehir TL McCarthy J Smith-Ravin IC Talbot,, et al. Br J Cancer 1998 77 1267 1274 9579832
10. Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib. K Taniguchi J Okami K Kodama M Higashiyama K Kato, Cancer Sci 2008 99 929 935 10.1111/j.1349-7006.2008.00782.x 18325048
11. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). CR Newton A Graham LE Heptinstall SJ Powell C Summers N Kalsheker JC Smith AF Markham, Nucleic Acids Res 1989 17 2503 2516 10.1093/nar/17.7.2503 2785681
12. A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping. D Whitcombe J Brownie HL Gillard D McKechnie J Theaker CR Newton S Little, Clin Chem 1998 44 918 923 9590362
13. Multiplexed assays for detection of mutations in PIK3CA. RE Board NJ Thelwell PF Ravetto S Little M Ranson C Dive A Hughes D Whitcombe, Clin Chem 2008 54 757 760 10.1373/clinchem.2007.098376 18375489
14. Development of a facile fluorescent assay for the detection of 80 mutations within the p53 gene. DR Hodgson CA Foy M Partridge S Pateromichelakis NJ Gibson, Mol Med 2002 8 227 237 12359953
15. An homogeneous fluorescence polymerase chain reaction assay to identify Salmonella. SY Tseng D Macool V Elliott G Tice R Jackson M Barbour D Amorese, Anal Biochem 1997 245 207 212 10.1006/abio.1996.9970 9056213
16. Rapid detection of subtelomeric deletion/duplication by novel real-time quantitative PCR using SYBR-green dye. D Boehm S Herold A Kuechler T Liehr F Laccone, Hum Mutat 2004 23 368 378 10.1002/humu.20011 15024731
17. Molecular predictors of outcome with gefitinib in a Phase III placebo-controlled study in advanced non-small-cell lung cancer. FR Hirsch M Varella-Garcia PA Bunn Jr WA Franklin R Dziadziuszko N Thatcher A Chang P Parikh J Rodrigues Pereira T Ciuleanu,, et al. J Clin Oncol 2006 24 5034 5042 10.1200/JCO.2006.06.3958 17075123
18. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. NJ Coombs AC Gough JN Primrose, Nucleic Acids Res 1999 27 12 10.1093/nar/27.16.e12 10454649
19. Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. RE Board G Ellison MC Orr KR Kemsley G McWalter LY Blockley SP Dearden C Morris M Ranson MV Cantarini,, et al. Br J Cancer 2009 101 1724 1730 10.1038/sj.bjc.6605371 19861964
20. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). H Kimura M Suminoe K Kasahara T Sone T Araya S Tamori F Koizumi K Nishio K Miyamoto M Fujimura,, et al. Br J Cancer 2007 97 778 784 10.1038/sj.bjc.6603949 17848912
21. Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. A Horiike H Kimura K Nishio F Ohyanagi Y Satoh S Okumura Y Ishikawa K Nakagawa T Horai M Nishio, Chest 2007 131 1628 1634 10.1378/chest.06-1673 17565015
22. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. H Kimura Y Fujiwara T Sone H Kunitoh T Tamura K Kasahara K Nishio, Cancer Sci 2006 97 642 648 10.1111/j.1349-7006.2006.00216.x 16827805 (Pubitemid 44056613)